Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01667965 · ClinicalTrials.gov registry record

Use of a Video Decision Tool to Improve Informed Decision-Making in Hospitalized Patients Considering Palliative Radiation Therapy

A clinical trial of Metastatic Cancer or Locally Advanced and Patients Receiving Palliative Radiation, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
43
Enrollment target
1
Study location

NCT01667965: Completed study of Metastatic Cancer or Locally Advanced and Patients Receiving Palliative Radiation, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01667965 is a study of Metastatic Cancer or Locally Advanced and Patients Receiving Palliative Radiation that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01667965, a study of Metastatic Cancer or Locally Advanced and Patients Receiving Palliative Radiation, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
43 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effectiveness and acceptability of a recently created informative video geared for patients who have been evaluated by a radiation oncologist for palliative radiation therapy during a hospitalization at Memorial Sloan-Kettering Cancer Center. Palliative radiation therapy is radiation therapy that is given to patients with the purpose of easing symptoms from cancer. It is not given with the intent to cure the cancer. The video presents basic information about palliative radiation and palliative care.

Primary Outcome

Effectiveness of the video tool will be assessed by the following measures before and after watching the video. The pre- and post-assessment design comparing uncertainty, knowledge and preference scores of a video explaining palliative radiation and palliative care.

Interventions

  • BEHAVIORAL questionnaires

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2012-08
Est. Completion 2015-07
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT01667965 record still lists

NCT01667965 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.

The record links to 2 conditions, with Metastatic Cancer or Locally Advanced appearing as the primary indexed condition, and to 1 intervention - of which questionnaires is the first listed.

NCT01667965 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01667965 about?

NCT01667965 is a clinical study titled "Use of a Video Decision Tool to Improve Informed Decision-Making in Hospitalized Patients Considering Palliative Radiation Therapy". The purpose of this study is to assess the effectiveness and acceptability of a recently created informative video geared for patients who have been evaluated by a radiation oncologist for palliative radiation therapy during a hospitalization at Memorial Sloan-Kettering Cancer Center. Palliative rad...

What is the current status of trial NCT01667965?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2012-08. Estimated completion is 2015-07.

What conditions does trial NCT01667965 study?

This clinical trial studies the following conditions: Metastatic Cancer or Locally Advanced, Patients Receiving Palliative Radiation.

What interventions are being tested in trial NCT01667965?

The interventions under investigation include: questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT01667965?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01667965 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01667965, the US trial registry maintained by the National Library of Medicine. NCT01667965 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.